Upstream Bio, Inc. Cash Flow Statement

Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -35.95M-65.64M
Depreciation and Depletion 0.06M0.09M
Share-based Compensation 3.43M6.00M
Gains from Investment Securities 4.17M6.49M
Non-cash Items 4.65M71.27M
Cash from Operations -37.93M-59.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.26M1.66M
Depreciation & Amortization (CF) 0.06M0.09M
Change in Working Capital
Change in Receivables -0.31M0.52M
Change in Account Payables 1.28M2.02M
Change in Accured Expenses 0.42M1.51M
Investing Activities
Capital Expenditures 0.14M0.51M
Change in Acquisitions & Divestments 46.29M231.63M
Cash from Investing Activities -82.84M-59.48M
Financing Activities
Change in Capital Stock
Shares Issued 0.12M272.72M
Preferred Shares Issued 80.00M149.92M
Misc.
Cash from Financing Activities 129.55M418.91M
Change in Cash 8.78M300.25M
Beginning Cash Balance 17.05M25.64M
Free Cash Flow -38.07M-59.68M
Net Cash Flow 8.78M300.25M